(Q28244815)

English

Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis

scientific article (publication date: October 2014)

In more languages

Statements

scholarly article

0 references

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis (English)

0 references

0 references

0 references

0 references

systematic review

1 reference

based on heuristic

inferred from title

irritable bowel syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Alexander C. Ford

1

object named as

Alexander C Ford

0 references

object named as

Paul Moayyedi

9

0 references

Eamonn M M Quigley

2

object named as

Eamonn M M Quigley

0 references

author name string

Brian E Lacy

3

0 references

Anthony J Lembo

4

0 references

Yuri A Saito

5

0 references

Lawrence R Schiller

6

0 references

Edy E Soffer

7

0 references

Brennan M R Spiegel

8

0 references

language of work or name

0 references

publication date

October 2014

0 references

The American Journal of Gastroenterology

0 references

109

0 references

1547-61; quiz 1546, 1562

0 references

10

0 references

Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038/AJG.2014.202

20 April 2017

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1038/AJG.2014.202

20 April 2017

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1038/AJG.2014.202

20 April 2017

A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life

1 reference

https://api.crossref.org/works/10.1038/AJG.2014.202

20 April 2017

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

20 April 2017

Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Rectal sensorimotor characteristics in female patients with idiopathic constipation with or without paradoxical sphincter contraction

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Mucosal cytokine imbalance in irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Chronic constipation: a survey of the patient perspective

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Irritable bowel syndrome: physicians' awareness and patients' experience

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

A mixture ofEscherichia coli(DSM 17252) andEnterococcus faecalis(DSM 16440) for treatment of the irritable bowel syndrome - A randomized controlled trial with primary care physicians

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E.-coli preparation (DSM17252) compared to placebo.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Effect of probiotics on symptoms in korean adults with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Gut microbiota is not modified by Randomized, Double-blind, Placebo-controlled Trial of VSL#3 in Diarrhea-predominant Irritable Bowel Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome--a double blind, placebo-controlled, randomized study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

A randomised controlled trial of a probiotic 'functional food' in the management of irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Single-blind follow-up study on the effectiveness of a symbiotic preparation in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Effect of composite yogurt enriched with acacia fiber and Bifidobacterium lactis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Fermented milk containing Lactobacillus casei strain Shirota reduces incidence of hard or lumpy stools in healthy population

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Effect of synbiotic in constipated adult women - a randomized, double-blind, placebo-controlled study of clinical response

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.202

21 January 2018

Identifiers

10.1038/AJG.2014.202

1 reference

https://api.fatcat.wiki/v0/release/2yifgennujcgpakcrsuybsg7fe

30 July 2022

based on heuristic

mapped directly with Wikidata item

10.1038/AJG.2014.202

0 references

Dimensions Publication ID

0 references

release_2yifgennujcgpakcrsuybsg7fe

1 reference

https://api.fatcat.wiki/v0/release/2yifgennujcgpakcrsuybsg7fe

30 July 2022

based on heuristic

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

https://api.fatcat.wiki/v0/release/2yifgennujcgpakcrsuybsg7fe

30 July 2022

based on heuristic

mapped directly with Wikidata item

ResearchGate publication ID

0 references

2-s2.0-84924921458

0 references

Springer Nature article ID

10.1038/ajg.2014.202

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28244815&oldid=1834215536"